Identification of the prognostic value of immune gene signature and infiltrating immune cells for esophageal cancer patients

Abstract

Our study indicated that the immune-related prognostic signature could serve as a novel biomarker for predicting patients' prognosis and providing new immunotherapy targets in ESCA.